SCHEMBL8196371

SCHEMBL8196371

COC(=O)c1cc2c(C)c(C)c(=O)oc2cc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CELA1 Q9UNI1 1/20 0.48
HSD17B3 P37058 1/20 0.47
MAOB P27338 2/20 0.47
ALDH1A2 O94788 1/20 0.46
ALDH2 P05091 1/20 0.46
ALDH1B1 P30837 1/20 0.46
ALDH1A3 P47895 1/20 0.46
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 3/20 0.46
HPGD P15428 3/20 0.46
HTT P42858 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
RAB9A P51151 3/20 0.45
POLB P06746 1/20 0.45
HSP90AA1 P07900 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MAPT P10636 1/20 0.43
GPR35 Q9HC97 1/20 0.43
CA12 O43570 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31262945 0.81 KDM4E (0.71) CELA1HSD17B3MAOBALDH2ALDH1A1
SCHEMBL8199613 0.81 KDM4E (0.71) CELA1HSD17B3MAOBALDH2ALDH1A1
SCHEMBL27617272 0.78 HSD17B3 (0.61) HSD17B3MAOBALDH1A2ALDH2ALDH1B1
SCHEMBL7485171 0.77 RAB9A (0.47) MAOBALDH1A1KDM4EHPGDRAB9A
SCHEMBL8807724 0.73 MAOB (0.60) HSD17B3MAOBALDH1A2ALDH2ALDH1B1
SCHEMBL9211053 0.72 MCL1 (0.63) HSD17B3MAOBALDH1A2ALDH2ALDH1B1
SCHEMBL18752500 0.72 KDM4E (0.63) MAOBALDH1A1KDM4EHPGDGPR35
SCHEMBL1109633 0.72 CA12 (0.65) ALDH1A1KDM4EHPGDHTTPOLB
SCHEMBL1538335 0.70 CA12 (0.63) ALDH1A1KDM4EHPGDHTTPOLB
SCHEMBL8980551 0.69 CA12 (0.57) ALDH1A1KDM4EHPGDHTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078724-A2 IMIDAZOLINDERIVATIVES THEIR PREPARATION AND THEIR PHARMACEUTICAL USE ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed